Yusuke Kamada - Biomolecular Research Laboratories, Takeda Pharmaceutical Company Limited

基本信息

Career Trajectory

Bio

Yusuke Kamada received the B.E. and M.E. degrees in applied photonics system technology from Chitose Institute of Science and Technology, Chitose, Japan, in 2005 and 2007, respectively. As his undergraduate and graduate research activities, he was engaged with arc measurements, optical measurements of contact surface damage, and development of the related evaluation system.

Research Interests

Papers共 39 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table 1 from LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B

Shinji Takagi, Yoshinori Ishikawa,Akio Mizutani, Shinji Iwasaki, Satoru Matsumoto,Yusuke Kamada, Toshiyuki Nomura,Kazuhide Nakamura

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 2, 3, and Figures from LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B

Shinji Takagi, Yoshinori Ishikawa,Akio Mizutani,Shinji Iwasaki, Satoru Matsumoto,Yusuke Kamada, Toshiyuki Nomura,Kazuhide Nakamura

openalex（2023）

Cited0Views0Bibtex

Bias-free Photo-electrochemical Water Splitting Driven by Large Photopotential of Epitaxial (pb,la)tio3 Ferroelectric Thin Films

Sang Hyo Kweon,Yusuke Kamada,Takashi Harada,Shuji Nakanishi,Yoshiharu Mukouyama,Isaku Kanno

ACS Applied Energy Materialsno. 2 (2022): 2606-2612

Cited2Views0Bibtex

A Retrospective Observational Study on the Administration Duration of Recombinant Human Soluble Thrombomodulin in Patients with Infection-induced Disseminated Intravascular Coagulation

Yuta Kanno,Junichi Mukai,Yusuke Kamada, Daisuke Sugawara,Rie Kubota,Katsuya Otori, Tetsuyuki Takaiwa

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)（2021）

Cited0Views0Bibtex

Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist Screening

Ryokichi Koyama,Yasunori Fukuda,Yusuke Kamada,Hideyuki Nakagawa, Darbi Witmer,Geza Ambrus-Aikelin,Bi-Ching Sang,Masaharu Nakayama,Hidehisa Iwata

Assay and Drug Development Technologies（2018）

Cited1Views0WOSBibtex

Discovery of Artificial VIPR2-antagonist Peptides Possessing Receptor- and Ligand-Selectivity

Kotaro Sakamoto,Ryokichi Koyama,Yusuke Kamada,Masanori Miwa,Akiyoshi Tani

Biochemical and Biophysical Research Communications（2018）

Cited15Views0WOSBibtex

T-448, a Specific Inhibitor of LSD1 Enzyme Activity, Improves Learning Function Without Causing Thrombocytopenia in Mice

Satoru Matsuda,Rina Baba,Hideyuki Oki,Shinji Morimoto,Masashi Toyofuku,Shigeru Igaki,Yusuke Kamada,Shinji Iwasaki,Kota Matsumiya,Ryosuke Hibino,Hiroko Kamada,Takeshi Hirakawa,Misa Iwatani, Ken Tsuchida,Ryujiro Hara,Mitsuhiro Ito,Haruhide Kimura

Neuropsychopharmacology（2018）

Cited38Views0WOSNATUREBibtex

Discovery of the First Selective and Cell-Active Eif4a3 Inhibitors

Masahiro Ito,Misa Iwatani-Yoshihara,Toshio Tanaka,Douglas R. Cary,Yusuke Kamada,Yoshihiro Ishibashi,Hideyuki Oki,Satoshi Sogabe,Shoichi Nakao,Daisuke Morishita,Takashi Ito,Hiromichi Kimura,Tomohiro Kawamoto,Samuel Aparicio,Atsushi Nakanishi,Yasuhiro Imaeda

CANCER RESEARCH（2018）

Cited1Views0Bibtex

Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma T Inverse Agonist

Hideyuki Nakagawa,Ryoukichi Koyama,Yusuke Kamada,Atsuko Ochida,Mitsunori Kono,Junya Shirai,Satoshi Yamamoto,Geza Ambrus-Aikelin,Bi-Ching Sang,Masaharu Nakayama

PHARMACOLOGY（2018）

Cited9Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn